Exploring patients' perspectives: a mixed methods study on Outpatient Parenteral Antimicrobial Therapy (OPAT) experiences.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
29 Apr 2024
Historique:
received: 20 02 2024
accepted: 19 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

Outpatient Parenteral Antimicrobial Therapy (OPAT), an alternative to inpatient intravenous antibiotic therapy, has shown benefits in international studies such as increased patient satisfaction. Because OPAT has been used only sporadically in Germany so far, no structured results on patients' experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany. This is an observational study in a German pilot region, including a survey of 58 patients on their experiences with OPAT, and in-depth interviews with 12 patients (explanatory-sequential mixed-methods design). Patients reported that they were satisfied with OPAT. That a hospital discharge was possible and anti-infective therapy could be continued in the home environment was rated as being particularly positive. In the beginning, many patients in the interviews were unsure about being able to administer the antibiotic therapy at home on their own. However, healthcare providers (doctors and pharmacy service provider staff) were able to allay these concerns. Patients appreciated regular contact with care providers. There were suggestions for improvement, particularly concerning the organization of the weekly check-up appointments and the provision of information about OPAT. Patients were generally satisfied with OPAT. However, the treatment structures in Germany still need to be expanded to ensure comprehensive and high-quality OPAT care. NCT04002453, https://www. gov/ , (registration date: 2019-06-21).

Sections du résumé

BACKGROUND BACKGROUND
Outpatient Parenteral Antimicrobial Therapy (OPAT), an alternative to inpatient intravenous antibiotic therapy, has shown benefits in international studies such as increased patient satisfaction. Because OPAT has been used only sporadically in Germany so far, no structured results on patients' experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany.
METHODS METHODS
This is an observational study in a German pilot region, including a survey of 58 patients on their experiences with OPAT, and in-depth interviews with 12 patients (explanatory-sequential mixed-methods design).
RESULTS RESULTS
Patients reported that they were satisfied with OPAT. That a hospital discharge was possible and anti-infective therapy could be continued in the home environment was rated as being particularly positive. In the beginning, many patients in the interviews were unsure about being able to administer the antibiotic therapy at home on their own. However, healthcare providers (doctors and pharmacy service provider staff) were able to allay these concerns. Patients appreciated regular contact with care providers. There were suggestions for improvement, particularly concerning the organization of the weekly check-up appointments and the provision of information about OPAT.
CONCLUSIONS CONCLUSIONS
Patients were generally satisfied with OPAT. However, the treatment structures in Germany still need to be expanded to ensure comprehensive and high-quality OPAT care.
TRIAL REGISTRATION BACKGROUND
NCT04002453, https://www.
CLINICALTRIALS RESULTS
gov/ , (registration date: 2019-06-21).

Identifiants

pubmed: 38685017
doi: 10.1186/s12913-024-11017-9
pii: 10.1186/s12913-024-11017-9
doi:

Substances chimiques

Anti-Infective Agents 0
Anti-Bacterial Agents 0

Banques de données

ClinicalTrials.gov
['NCT04002453']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

544

Informations de copyright

© 2024. The Author(s).

Références

Terhalle E, Jung N, Stegemann MS, Priesner V, Lehmann C, Schmiedel S. Neue Entwicklungen in der ambulanten parenteralen Antibiotikatherapie (APAT). [New developments in outpatient parenteral antibiotic therapy (OPAT)]. Dtsch Med Wochenschr. 2020;145:1688–94. https://doi.org/10.1055/a-1114-3990 .
doi: 10.1055/a-1114-3990 pubmed: 33202453
Stegemann M, Hagel S, Lehmann C. Antibiotikatherapie (2): Ambulante parenterale Gabe. Deutsches Ärzteblatt Online. 2019. https://doi.org/10.3238/PersInfek.2019.07.22.03 .
doi: 10.3238/PersInfek.2019.07.22.03
Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, et al. 2018 infectious diseases society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2019;68:e1–35. https://doi.org/10.1093/cid/ciy745 .
doi: 10.1093/cid/ciy745 pubmed: 30423035
Petrak RM, Skorodin NC, Fliegelman RM, Hines DW, Chundi VV, Harting BP. Value and clinical impact of an infectious disease-supervised outpatient parenteral antibiotic therapy program. Open Forum Infect Dis. 2016;3:ofw193. https://doi.org/10.1093/ofid/ofw193 .
doi: 10.1093/ofid/ofw193 pubmed: 27807591 pmcid: 5088696
Rentala M, Andrews S, Tiberio A, Alagappan K, Tavdy T, Sheppard P, Silverman R. Intravenous home infusion therapy instituted from a 24-hour clinical decision unit for patients with cellulitis. Am J Emerg Med. 2016;34:1273–5. https://doi.org/10.1016/j.ajem.2016.04.022 .
doi: 10.1016/j.ajem.2016.04.022 pubmed: 27182030
Kayley J, Berendt AR, Snelling MJ, Moore H, Hamilton HC, Peto TE, et al. Safe intravenous antibiotic therapy at home: experience of a UK based programme. J Antimicrob Chemother. 1996;37:1023–9. https://doi.org/10.1093/jac/37.5.1023 .
doi: 10.1093/jac/37.5.1023 pubmed: 8737154
Dalovisio JR, Juneau J, Baumgarten K, Kateiva J. Financial impact of a home intravenous antibiotic program on a medicare managed care program. Clin Infect Dis. 2000;30:639–42. https://doi.org/10.1086/313755 .
doi: 10.1086/313755 pubmed: 10770722
Wolter JM, Cagney RA, McCormack JG. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. J Infect. 2004;48:263–8. https://doi.org/10.1016/S0163-4453(03)00135-X .
doi: 10.1016/S0163-4453(03)00135-X pubmed: 15001305
Dimitrova M, Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. BMJ Open. 2021;11:e049733.  https://doi.org/10.1136/bmjopen-2021-049733
doi: 10.1136/bmjopen-2021-049733 pubmed: 34588251 pmcid: 8479950
Giuliano G, Raffaelli F, Faliero D, Tamburrini E, Tarantino D, Nurchis MC, Scoppettuolo G. Outpatient parenteral antimicrobial therapy (OPAT) from an emergency model applied during the COVID-19 pandemic to standard of care: preliminary lessons from our experience. Infect Dis Now. 2023;53;104642.  https://doi.org/10.1016/j.idnow.2023.01.002
doi: 10.1016/j.idnow.2023.01.002 pubmed: 36642101 pmcid: 9836987
Berrevoets MAH, Oerlemans AJM, Tromp M, Kullberg BJ, ten Oever J, Schouten JA, Hulscher ME. Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study. BMJ Open. 2018;8: e024564. https://doi.org/10.1136/bmjopen-2018-024564 .
doi: 10.1136/bmjopen-2018-024564 pubmed: 30420352 pmcid: 6252647
Wong KK, Fraser TG, Shrestha NK, Fatica C, Deshpande A. Low incidence of Clostridium difficile infection (CDI) in patients treated with outpatient parenteral antimicrobial therapy (OPAT). Infect Control Hosp Epidemiol. 2015;36:110–2. https://doi.org/10.1017/ice.2014.6 .
doi: 10.1017/ice.2014.6 pubmed: 25627769
MacKenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int J Antimicrob Agents. 2014;43:7–16. https://doi.org/10.1016/j.ijantimicag.2013.09.006 .
doi: 10.1016/j.ijantimicag.2013.09.006 pubmed: 24200469
Staples JA, Ho M, Ferris D, Hayek J, Liu G, Tran KC, Sutherland JM. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs. Clin Infect Dis. 2022;75:1921–9. https://doi.org/10.1093/cid/ciac298 .
doi: 10.1093/cid/ciac298 pubmed: 35439822
Board N, Brennan N, Caplan GA. A randomised controlled trial of the costs of hospital as compared with hospital in the home for acute medical patients. Aust N Z J Public Health. 2000;24:305–11. https://doi.org/10.1111/j.1467-842x.2000.tb01573.x .
doi: 10.1111/j.1467-842x.2000.tb01573.x pubmed: 10937409
Corwin P, Toop L, McGeoch G, Than M, Wynn-Thomas S, Wells JE, et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ. 2005;330:129. https://doi.org/10.1136/bmj.38309.447975.EB .
doi: 10.1136/bmj.38309.447975.EB pubmed: 15604157 pmcid: 544431
Chapman ALN, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67:1053–62. https://doi.org/10.1093/jac/dks003 .
doi: 10.1093/jac/dks003 pubmed: 22298347
Hatcher J, Costelloe C, Cele R, Viljanen A, Samarasinghe D, Satta G, et al. Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London service. Int J Antimicrob Agents. 2019;54:207–14. https://doi.org/10.1016/j.ijantimicag.2019.04.008 .
doi: 10.1016/j.ijantimicag.2019.04.008 pubmed: 30986525
Rieg S, Küpper MF. Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany. Infection. 2016;44:159–66. https://doi.org/10.1007/s15010-016-0883-1 .
doi: 10.1007/s15010-016-0883-1 pubmed: 26908131
Schmidt-Hellerau K, Baade N, Günther M, Scholten N, Lindemann CH, Leisse C, et al. Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. Infection. 2024. https://doi.org/10.1007/s15010-024-02199-9 .
doi: 10.1007/s15010-024-02199-9 pubmed: 38478255
Scholten N, Leisse C, Brandes V, Oberröhrmann C, Ihle P, Peter S, et al. Outpatient parenteral antimicrobial therapy in Germany: a prospective cohort study protocol. BMJ Open. 2022;12:e061417. https://doi.org/10.1136/bmjopen-2022-061417 .
doi: 10.1136/bmjopen-2022-061417 pubmed: 36375971 pmcid: 9664305
Cresswell JW. A concise introduction to mixed methods research. 2nd ed. Thousand Oaks, CA: SAGE Publications; 2022.
Ansari AA. Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Kingdom of Bahrain: Efficacy. Patient Satisfaction and Cost Effectiveness TOIDJ. 2013;7:90–5. https://doi.org/10.2174/1874279301307010090 .
doi: 10.2174/1874279301307010090
Baecker H, Gessmann J, Hanusrichter Y, Zahn PK, Schildhauer TA, Frieler S. Die ambulante i. v. Antibiotikatherapie mittels PICC Line in der Behandlung von chronischen periprothetischen Infektionen. [Outpatient Parenteral Antibiotic Therapy (OPAT) with Peripherally Inserted Central Catheter in Patients with Periprosthetic Joint Infection]. Z Orthop Unfall. 2019;157:510–4. https://doi.org/10.1055/a-0830-4776 .
doi: 10.1055/a-0830-4776 pubmed: 31387123
Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, Scaglione F. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004;24:473–8. https://doi.org/10.1016/j.ijantimicag.2004.06.004 .
doi: 10.1016/j.ijantimicag.2004.06.004 pubmed: 15519480
Saillen L, Arensdorff L, Moulin E, Voumard R, Cochet C, Boillat-Blanco N, et al. Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps. Eur J Clin Microbiol Infect Dis. 2017;36:1387–92. https://doi.org/10.1007/s10096-017-2944-5 .
doi: 10.1007/s10096-017-2944-5 pubmed: 28283831
Townsend J, Keller S, Tibuakuu M, Thakker S, Webster B, Siegel M, et al. Outpatient parenteral therapy for complicated Staphylococcus aureus infections: a snapshot of processes and outcomes in the real world. Open Forum Infect Dis. 2018;5:ofy274. https://doi.org/10.1093/ofid/ofy274 .
doi: 10.1093/ofid/ofy274 pubmed: 30488039 pmcid: 6251475
Twiddy M, Czoski Murray CJ, Mason SJ, Meads D, Wright JM, Mitchell ED, Minton J. A qualitative study of patients’ feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvement. BMJ Open. 2018;8:e019099. https://doi.org/10.1136/bmjopen-2017-019099
doi: 10.1136/bmjopen-2017-019099 pubmed: 29326190 pmcid: 5781150
Gardiol C, de Vallière S. Ambulante parenterale Antibiotikatherapie: Aktuelle Empfehlungen für die parenterale Behandlung von Infektionen. Swiss Medical Forum - Schweizerisches Medizin-Forum. 2016;16:314–8.
doi: 10.4414/smf.2016.02620
Lehmann C, Leisse C, Lindemann C, Scholten N, Oberröhrmann C, Ihle P, et al. Ergebnisbericht: Ambulante parenterale Antibiotikatherapie in der Kölner Metropolregion (K-APAT). 2023. https://innovationsfonds.g-ba.de/downloads/beschluss-dokumente/436/2023-08-16_K-APAT_Ergebnisbericht.pdf . Accessed 26 Mar 2024.
Kuckartz U. Qualitative Inhaltsanalyse: Methoden, Praxis, Computerunterstützung. 4th ed. Weinheim: Beltz Verlagsgruppe; 2018.
Quintens C, Steffens E, Jacobs K, Schuermans A, van Eldere J, Lagrou K, et al. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program. Infection. 2020;48:357–66. https://doi.org/10.1007/s15010-020-01398-4 .
doi: 10.1007/s15010-020-01398-4 pubmed: 32060859
Gonçalves-Bradley DC, Lannin NA, Clemson L, Cameron ID, Shepperd S. Discharge planning from hospital. Cochrane Database Syst Rev. 2022;2:CD000313.
pubmed: 35199849
Mäkelä P, Stott D, Godfrey M, Ellis G, Schiff R, Shepperd S. The work of older people and their informal caregivers in managing an acute health event in a hospital at home or hospital inpatient setting. Age Ageing. 2020;49:856–64. https://doi.org/10.1093/ageing/afaa085 .
doi: 10.1093/ageing/afaa085 pubmed: 32428202 pmcid: 7444665
Chambers ST, Basevi A, Gallagher K, Carswell-Moyna A, Isenman H, Pithie A, et al. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on. N Z Med J. 2019;132:21–32.
pubmed: 31851658
Hase R, Yokoyama Y, Suzuki H, Uno S, Mikawa T, Suzuki D, et al. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan. Int J Infect Dis. 2020;95:210–5. https://doi.org/10.1016/j.ijid.2020.03.033 .
doi: 10.1016/j.ijid.2020.03.033 pubmed: 32205285
Kwok CS, Whittaker JJ, Malbon C, White B, Snape J, Lloyd V, et al. Outpatient parenteral antimicrobial therapy (OPAT) service is associated with inpatient-bed cost savings. Br J Cardiol. 2021;28:38. https://doi.org/10.5837/bjc.2021.038 .
doi: 10.5837/bjc.2021.038 pubmed: 35747699 pmcid: 8988795
Al Shareef HJ, Al Harbi A, Alatawi Y, Aljabri A, Al-Ghanmi MA, Alzahrani MS, et al. Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study. Antibiotics (Basel). 2022. https://doi.org/10.3390/antibiotics11040441 .
doi: 10.3390/antibiotics11040441 pubmed: 35453192
Schoonenboom J, Johnson RB. How to Construct a Mixed Methods Research Design. Kolner Z Soz Sozpsychol. 2017;69:107–31. https://doi.org/10.1007/s11577-017-0454-1 .
doi: 10.1007/s11577-017-0454-1 pubmed: 28989188 pmcid: 5602001
Bundesministerium für Justiz. Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung - § 39 Krankenhausbehandlung; 1988. https://www.gesetze-im-internet.de/sgb_5/__39.html . Accessed 26 Mar 2024.
Chapman ALN, Patel S, Horner C, Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy: updated recommendations from the UK. J Antimicrob Chemother. 2019;74:3125–7. https://doi.org/10.1093/jac/dkz343 .
doi: 10.1093/jac/dkz343 pubmed: 31504575

Auteurs

Sophie Peter (S)

Chair of General Practice II and Patient-Centredness in Primary Care, Institute of General Practice and Primary Care, Faculty of Health, Witten/Herdecke University, Witten, Germany. sophie.peter@uni-wh.de.
University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research and Rehabilitation Science, Chair of Health Services Research, Cologne, Germany. sophie.peter@uni-wh.de.

Charlotte Oberröhrmann (C)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research and Rehabilitation Science, Chair of Health Services Research, Cologne, Germany.

Holger Pfaff (H)

University of Cologne, Faculty of Human Sciences and Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research and Rehabilitation Science Cologne, Cologne, Germany.
Center for Health Services Research Cologne, Cologne, Germany.

Clara Lehmann (C)

Department I of Internal Medicine, Medical Faculty, University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

Kirsten Schmidt-Hellerau (K)

Department I of Internal Medicine, Medical Faculty, University Hospital Cologne, University of Cologne, Cologne, Germany.

Vanessa Brandes (V)

Department I of Internal Medicine, Medical Faculty, University Hospital Cologne, University of Cologne, Cologne, Germany.

Charlotte Leisse (C)

Department I of Internal Medicine, Medical Faculty, University Hospital Cologne, University of Cologne, Cologne, Germany.

Christoph Heinrich Lindemann (CH)

Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC),, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Peter Ihle (P)

PMV forschungsgruppe, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Jutta Küpper-Nybelen (J)

PMV forschungsgruppe, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Anna Hagemeier (A)

Institute of Medical Statistics and Computational Biology (IMSB), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Nadine Scholten (N)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research and Rehabilitation Science, Chair of Health Services Research, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH